| Phenotypic Profile |
| Category |
Entity |
Quantity |
Experimental Paradigm |
Age at Testing |
| Emotion |
Anxiety1 |
Ameliorated
Description: Treatment with antalarmin reduces anxiety and increases time spent in open arms or lit chamber in elevated plus maze and ligh-dark exploration test respectivel
Exp Paradigm: Light-dark exploration test
|
Light-dark exploration test |
2-3 month |
| |
|
Description: Treatment with antalarmin reduces anxiety and increases time spent in open arms or lit chamber in elevated plus maze and ligh-dark exploration test respectivel
Exp Paradigm: Light-dark exploration test |
|
|
| Emotion |
Anxiety1 |
Ameliorated
Description: Treatment with antalarmin reduces anxiety and increases time spent in open arms or lit chamber in elevated plus maze and ligh-dark exploration test respectivel
Exp Paradigm: Elevated plus maze test
|
Elevated plus maze test |
2-3 month |
| |
|
Description: Treatment with antalarmin reduces anxiety and increases time spent in open arms or lit chamber in elevated plus maze and ligh-dark exploration test respectivel
Exp Paradigm: Elevated plus maze test |
|
|
| Emotion |
Anxiety1 |
Ameliorated
Description: Treatment with antalarmin reduces anxiety levels even in mecp2-tg mice previously exposed to social defeat stress prior to testing in elevated plus maze
Exp Paradigm: NA
|
Post-stress elevated plus maze test |
2-3 month |
| |
|
Description: Treatment with antalarmin reduces anxiety levels even in mecp2-tg mice previously exposed to social defeat stress prior to testing in elevated plus maze
Exp Paradigm: NA |
|
|
|
| Not Reported: |
Circadian sleep/wake cycle, Communications, Developmental profile, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior, |
